SCHEMBL7062256

SCHEMBL7062256

Cc1ccc(S(=O)(=O)ON(N=Cc2cc([N+](=O)[O-])ccc2F)C(=N)N)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.41
LMNA P02545 7/20 0.41
TDP1 Q9NUW8 2/20 0.41
POLB P06746 1/20 0.39
GAA P10253 4/20 0.37
MAPT P10636 10/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
HCRTR1 O43613 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP19A1 P11511 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7066729 0.89 ALDH1A1 (0.53) ALDH1A1LMNATDP1POLBGAA
SCHEMBL7062491 0.88 ALDH1A1 (0.44) ALDH1A1LMNATDP1POLBGAA
SCHEMBL7062930 0.86 ALDH1A1 (0.39) ALDH1A1LMNATDP1POLBGAA
SCHEMBL7066010 0.84 GRIN2D (0.41) ALDH1A1LMNATDP1GAAMAPT
SCHEMBL7062984 0.84 MAPT (0.33) ALDH1A1LMNATDP1GAAMAPT
SCHEMBL7062480 0.83 ALDH1A1 (0.47) ALDH1A1LMNAPOLBGAAMAPT
SCHEMBL915169 0.82 ALDH1A1 (0.53) ALDH1A1LMNATDP1POLBMAPT
SCHEMBL7062251 0.82 ALDH1A1 (0.42) ALDH1A1LMNATDP1POLBGAA
SCHEMBL7062246 0.82 ALDH1A1 (0.42) ALDH1A1LMNATDP1POLBGAA
SCHEMBL7060993 0.82 MAPT (0.42) ALDH1A1LMNATDP1POLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP disclosed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO disclosed